Comparison Tool
Compare Peptides
Compare two peptides side-by-side to see which might be right for your goals.
Comparison
Semaglutide
Tirzepatide
Approval Status
FDA Approved
FDA Approved
Also Known As
Ozempic/Wegovy
Mounjaro/Zepbound
Category
Weight Loss
Weight Loss
Mechanism
GLP-1 agonist
Dual GLP-1/GIP agonist
Avg Weight Loss
15-20%
20-25%
Dosing Frequency
Weekly
Weekly
Form Options
Injection, Oral tablet
Injection only
Cost Estimate
$$$
$$$$
Side Effect Severity
Moderate
Moderate
Research Level
Extensive
Extensive
Key Benefit
Proven efficacy, cardiovascular benefits
Best weight loss results in class
Biggest Downside
Nausea common, expensive
Expensive, injection only
Best For
Mainstream weight loss with medical backing
Maximum weight loss results
Learn more about Semaglutide
Proven efficacy, cardiovascular benefits
Learn more about Tirzepatide
Best weight loss results in class